Literature DB >> 8842492

Tumor angiogenesis: a physiological process or genetically determined?

P A D'Amore1, D T Shima.   

Abstract

Continued tumor growth is dependent upon the growth of new blood vessels. This commentary reviews the mechanisms whereby tumors become vascularized and examines whether tumor angiogenesis is solely an example of a normal physiologic process or is part of the genetic program of the tumor. The likelihood that neovascularization of tumors combines both of these components, that is, utilizing tumor-specific elements as well as capacities common to all cells, is discussed.

Entities:  

Mesh：

Year:  1996        PMID： 8842492     DOI： 10.1007/bf00437473

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


  36 in total

Review 1.  Angiogenesis inhibitors generated by tumors.

Authors:  J Folkman
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

2.  Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

Authors:  J Kandel; E Bossy-Wetzel; F Radvanyi; M Klagsbrun; J Folkman; D Hanahan
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

3.  Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

Authors:  D T Shima; A P Adamis; N Ferrara; K T Yeo; T K Yeo; R Allende; J Folkman; P A D'Amore
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

4.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Authors:  A P Adamis; D T Shima; M J Tolentino; E S Gragoudas; N Ferrara; J Folkman; P A D'Amore; J W Miller
Journal:  Arch Ophthalmol       Date:  1996-01

5.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Authors:  E A Pierce; R L Avery; E D Foley; L P Aiello; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

6.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

Authors:  K M Dameron; O V Volpert; M A Tainsky; N Bouck
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

Review 9.  Development and adaptability of microvasculature in skeletal muscle.

Authors:  O Hudlická
Journal:  J Exp Biol       Date:  1985-03       Impact factor: 3.312

10.  Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta.

Authors:  A RayChaudhury; W A Frazier; P A D'Amore
Journal:  J Cell Sci       Date:  1994-01       Impact factor: 5.285
View more
  5 in total

Review 1.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

2.  VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue.

Authors:  Robert Partyka; Maciej Gonciarz; Przemysław Jałowiecki; Danuta Kokocińska; Tomasz Byrczek
Journal:  Med Sci Monit       Date:  2012-04

3.  Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1.

Authors:  Kakali Dhar; Gopal Dhar; Monami Majumder; Inamul Haque; Smita Mehta; Peter J Van Veldhuizen; Sushanta K Banerjee; Snigdha Banerjee
Journal:  Mol Cancer       Date:  2010-08-05       Impact factor: 27.401

4.  The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts.

Authors:  T Danielsen; E K Rofstad
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

5.  Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation.

Authors:  Feng Ran; Wendong Li; Yi Qin; Tong Yu; Zhao Liu; Min Zhou; Cheng Liu; Tong Qiao; Xiaoqiang Li; Reda G Yousef; Ibrahim H Eissa; Mohamed M Khalifa
Journal:  Oxid Med Cell Longev       Date:  2021-10-28       Impact factor: 6.543
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.